CM
SNDX icon

Caption Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Caption Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-504,471
Closed -$6.6M – 2017
2025
Q2 		$4.72M Buy
504,471
+322,571
+177% +$3.55M 0.05% 422
2025
Q1 		$2.23M Sell
181,900
-32,767
-15% -$462K 0.02% 650
2024
Q4 		$2.84M Buy
214,667
+194,341
+956% +$3.33M 0.03% 572
2024
Q3 		$391K Buy
+20,326
New +$420K 0.01% 970
2023
Q4 		– Sell
-9,302
Closed -$143K – 1646
2023
Q3 		$135K Sell
9,302
-2,498
-21% -$47.3K ﹤0.01% 1129
2023
Q2 		$247K Sell
11,800
-3,200
-21% -$66.6K ﹤0.01% 909
2023
Q1 		$317K Buy
+15,000
New +$373K 0.01% 871
2022
Q1 		– Sell
-46,226
Closed -$1.01M – 1908
2021
Q4 		$1.01M Buy
+46,226
New +$854K 0.01% 1044
2021
Q3 		– Sell
-19,629
Closed -$337K – 1779
2021
Q2 		$337K Sell
19,629
-33,371
-63% -$611K ﹤0.01% 1116
2021
Q1 		$1.19M Buy
53,000
+20,000
+61% +$452K 0.03% 645
2020
Q4 		$733K Buy
33,000
+21,886
+197% +$454K 0.02% 667
2020
Q3 		$164K Buy
+11,114
New +$169K ﹤0.01% 924
2019
Q4 		– Sell
-500
Closed -$3.67K – 992
2019
Q3 		$4K Buy
+500
New +$4.55K ﹤0.01% 679
2019
Q1 		– Sell
-84,666
Closed -$377K – 718
2018
Q4 		$377K Buy
84,666
+32,666
+63% +$179K 0.03% 363
2018
Q3 		$421K Buy
+52,000
New +$371K 0.02% 426

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Caption Management's SNDX Position: Q3 2025 in Review

Caption Management sold out of Syndax Pharmaceuticals (SNDX) in Q3 2025, closing a stake of 504,471 shares — an estimated $6.6M sold.

Caption Management first reported a position in SNDX in Q3 2018 and held it in 15 quarters. The position peaked at $4.72M in Q2 2025. 227 funds tracked by Wall St. Rank hold SNDX as of Q3 2025.

  • Caption Management reported no remaining Syndax Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Caption Management sold 504,471 Syndax Pharmaceuticals shares in Q3 2025, an estimated $6.6M.
  • Caption Management first reported a position in Syndax Pharmaceuticals in Q3 2018 and held it in 15 quarters.
  • Caption Management's Syndax Pharmaceuticals position peaked at $4.72M in Q2 2025.
  • 227 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.